Emerging Diseases Archives - Infectious Disease Advisor

Incidence Rates of SARS-CoV-2 Similar for Children and Adults

October 20, 2021

More infections asymptomatic among children, with 52 percent asymptomatic among those aged 0 to 4 years versus 12 percent in adults.

COVID19

T-Cell and Humoral Response to SARS-CoV-2 Vaccine in Patients With MS on Ocrelizumab

By

Amit Akirov, MD

October 15, 2021

Researchers sought to determine the T-cell and antibody response to the SARS-CoV-2 vaccine in patients with multiple sclerosis treated with ocrelizumab, compared with healthy individuals.

The Denver City Council recently passed an ordinance to allow the nation’s first supervised injection site. The Colorado General Assembly must also render an approval. A bipartisan bill to allow the site narrowly failed in a Republican-controlled Senate in 2018, but party control will change in 2019, making its passage more likely.3 Meanwhile, cities including San Francisco and Philadelphia are moving forward with their own site plans, despite warnings from the US Justice Department. Whether in Denver, San Francisco, Philadelphia, or elsewhere, expect the first supervised injection site in the United States to open in the near future, and for a legal battle to follow.

COVID19, News

Breakthrough COVID-19 Risk Up for Patients With Substance Use Disorders

October 15, 2021

After controlling for lifetime comorbidities and adverse socioeconomic determinants of health, infection risk increased only for cannabis use disorder.

COVID19

Nearly 200,000 COVID-19 Home Tests Recalled Over False Positives

October 14, 2021

Problem with the rapid antigen tests was caused by variations in the quality of one of the raw materials used in the products

COVID19

The Effect of MS Treatments on SARS-CoV-2 Vaccines and the Humoral Response

By

Amit Akirov, MD

October 13, 2021

Researchers determined the impact of other disease-modifying treatments in multiple sclerosis and the effect of delaying anti-CD20 infusion on the humoral response to COVID-19 vaccines.

COVID19

Higher Risk for Mortality and Poor Outcomes Among Patients With SLE Hospitalized With COVID-19-Associated ARDS

By

Sheila Jacobs

October 13, 2021

Researchers assessed the risk for mortality and poor outcomes in patients with systemic lupus erythematosus hospitalized with COVID-19 acute respiratory distress syndrome.